CVS, Teva, Allergan and Endo reach $878 million deal with Florida over the opioid crisis

On the eve of a trial, the state of Florida has reached a settlement with a major pharmacy chain and two drug manufacturers over their roles in fomenting the opioid crisis that has gripped the United States for more than two decades.

CVS Health will pay $484 million, and Allergan —a unit of AbbVie — agreed to pay $134 million to settle a lawsuit filed by the state. In addition, Teva Pharmaceuticals will pay $195 million, and also provide $84 million worth of its generic version of Narcan, a nasal spray that is used to treat opioid overdoses in emergencies.

A separate settlement with Endo International was also finalized; the company agreed to pay $65 million. Walgreens, however, did not reach a deal and faces a trial that is scheduled to begin on April 5.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In